Compare AUB & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUB | ALKS |
|---|---|---|
| Founded | 1902 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.5B |
| IPO Year | N/A | 2012 |
| Metric | AUB | ALKS |
|---|---|---|
| Price | $37.60 | $30.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $41.81 | ★ $43.43 |
| AVG Volume (30 Days) | 865.0K | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | N/A | ★ $1,475,899,000.00 |
| Revenue This Year | $29.24 | $24.94 |
| Revenue Next Year | $4.52 | $3.47 |
| P/E Ratio | ★ $19.68 | $21.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.85 | $25.17 |
| 52 Week High | $42.18 | $36.32 |
| Indicator | AUB | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 38.26 |
| Support Level | $34.59 | $27.77 |
| Resistance Level | $40.71 | $31.69 |
| Average True Range (ATR) | 1.36 | 1.12 |
| MACD | -0.47 | -0.50 |
| Stochastic Oscillator | 24.27 | 19.26 |
Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.